Halozyme Therapeutics Inc. (HALO)

15.73
NASDAQ : Health Technology
Prev Close 15.84
Day Low/High 15.68 / 16.00
52 Wk Low/High 13.24 / 19.56
Avg Volume 793.30K
Exchange NASDAQ
Shares Outstanding 145.51M
Market Cap 2.30B
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Spectrum Shares Surge on Data for Lung Cancer Drug -- Biotech Movers

Spectrum Shares Surge on Data for Lung Cancer Drug -- Biotech Movers

The Henderson, Nev.-based company said interim data from a Phase 2 study showed an objective response rate of 73%.

Shark Bites: Market Starts Selling the News Even Before Trump Talks Taxes

Shark Bites: Market Starts Selling the News Even Before Trump Talks Taxes

Proposals are having an effect ahead of afternoon announcement.

Strong Action in Individual Stocks Starts to Feel a Bit Frothy

Strong Action in Individual Stocks Starts to Feel a Bit Frothy

It's hard to predict when momentum will slow, but it could be time to take some profits when the market is as strong as this morning.

Good Stocks Are There for the Picking

Good Stocks Are There for the Picking

Focus on what could go right.

There Are Good Opportunities in Stock Picking

There Are Good Opportunities in Stock Picking

The indices may need a rest, but stock-pickers have an edge.

Slowly but Surely, Post-Fed Euphoria Dissipates

Slowly but Surely, Post-Fed Euphoria Dissipates

The market response to the Fed was quite extreme, although there really wasn't any major development.

Are Your Stocks Just Running in Place?

Are Your Stocks Just Running in Place?

If investing is like a horserace, you can change horses in the middle of the race.

Bullish & Bearish Reversals for the Week

Bullish & Bearish Reversals for the Week

Energy and consumer defensive names dominate on the bearish side.

Netflix Can Break out Soon

Netflix Can Break out Soon

Plus, charts from ALGN, HALO and CME.

Biotech: Partnerships Spell Success

Biotech: Partnerships Spell Success

Bet on small-caps with big-name collaborators.

So-So Start, But GoPro Is Going Higher

The market is off to a tepid start after rallying for three straight days -- certainly understandable, and some profit taking should be expected as we trade up near the highs of the relatively narrow trading range that has existed throughout most of...

Playing Biotechs with the House's Money

Playing Biotechs with the House's Money

Here's how to lock in gains on risky small-cap biotechnology stocks.

Market Gains Steam

Stocks have gotten stronger since our last update, as the S&P 500 and DJIA have joined the Nasdaq in positive territory. Oil is giving back a little of its recent gains. One can see how lower jet fuel costs are bolstering airline earnings. Fuel cost...

Partnerships Lift Small Caps

Partnerships Lift Small Caps

Watch for small biotechs partnering with bigger firms.

Premarket Musings

As always, it is my pleasure to be filling in for Doug Kass on the Daily Diary today. Earnings reports will continue to flow in as we are in the heart of first-quarter earnings seasons, which, as usual, is coming in a little better than expectations...

How I Play the Biotechs

How I Play the Biotechs

A strategy to immunize biotech investors from regret.

Biotech Stocks at a Crossroad

Own them, or take something off the table?

Take Aim at Threshold Pharmaceuticals

Take Aim at Threshold Pharmaceuticals

A small biotech gem with lots of potential.

The Next Biotech Breakout?

As always, I am happy to be standing in for Doug Kass today on the Daily Diary (this Friday from sunny Miami). It looks like it will be an up open to talk about based on early market futures. The euro is heading towards its best week in 18 months, e...

Small-Cap Focus: Navidea

Small-Cap Focus: Navidea

Aggressive investors should look at a small speculative position.

Biotechs Enliven Familiar Pattern

Buying was more sedate than it has been.

A Steady but Sloppy Day

Awaiting Yellen, but some churn wouldn't hurt.

Small-Cap Friday's Little Gem

Small-Cap Friday's Little Gem

One small pharmaceutical company has big potential.

The Trend Is Up

Fighting this market isn't a money maker.

Two Small-Cap Biotechs To Consider

Two Small-Cap Biotechs To Consider

Fibrocell Science and Prothena have several 'shots on goal.'

Where's the Worry?

It may not feel intuitive to embrace this market, but it works.

Why I'm Sticking With Biotech

Why I'm Sticking With Biotech

They offer a nice shelter for the headwinds now hitting equities.

Get Off the Energy Roller Coaster

Get Off the Energy Roller Coaster

Try these two small biotechs with no connection to the gyrations of energy markets.